SHINPOONG PHARMACEUTICAL CO.,LTD
R&D-driven pharma firm making APIs, finished drugs, and medical products for global markets.
019170 | KO
Overview
Corporate Details
- ISIN(s):
- KR7019170000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 안산시 단원구 원시로 7, 안산시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Shinpoong Pharmaceutical Co., Ltd. is an R&D-oriented multinational pharmaceutical company that manufactures and markets a range of pharmaceutical products, active pharmaceutical ingredients (APIs), and finished drugs. The company is committed to advancing pharmaceutical technologies and produces various remedy drugs and specialized medical products, such as its anti-adhesion barrier, Medicurtain. With a global presence that includes multiple manufacturing sites and international supply agreements, the company serves both domestic and overseas markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.6 MB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 2.1 MB | ||
| 2025-06-27 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (유행성 RNA 바이러스 감염질환의 예방 또는 치료용 약제학적 조성물_국내특허취득)
|
Korean | 7.4 KB | ||
| 2025-06-16 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (유행성 RNA 바이러스 감염질환의 예방 또는 치료용 약제학적 조성물_특허취득)
|
Korean | 7.5 KB | ||
| 2025-05-30 00:00 |
Regulatory News Service
불성실공시법인지정
|
Korean | 7.2 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.7 MB | ||
| 2025-05-15 00:00 |
Quarterly Report
[기재정정]분기보고서 (2025.03)
|
Korean | 1.7 MB | ||
| 2025-05-12 00:00 |
Regulatory News Service
불성실공시법인지정예고
|
Korean | 6.0 KB | ||
| 2025-05-08 00:00 |
Legal Proceedings Report
횡령ㆍ배임사실확인
|
Korean | 9.5 KB | ||
| 2025-04-03 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (골관절염 주사요법제 SP5M002주의 임상 3상 시험 Topline 결과 발표)
|
Korean | 14.8 KB | ||
| 2025-03-28 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 18.7 KB | ||
| 2025-03-20 00:00 |
Annual Report
[첨부추가]사업보고서 (2024.12)
|
Korean | 2.1 MB | ||
| 2025-03-19 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 20.9 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 7.8 KB | ||
| 2025-03-07 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 144.2 KB |
Automate Your Workflow. Get a real-time feed of all SHINPOONG PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SHINPOONG PHARMACEUTICAL CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SHINPOONG PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
